Chegg Inc

This advisory 'say-on-pay' proposal asks stockholders to approve the 2025 compensation of named executive officers as disclosed in the proxy statement. Management seeks approval to confirm that its pay practices — a mix of base salary, a performance-oriented annual incentive, and significant equity-based long‑term incentives (including time‑based RSUs and performance-based PSUs) — are consistent with stockholder interests and effective at attracting, motivating, and retaining executive talent during a period of strategic transition. The company emphasizes pay‑for‑performance mechanisms: a bifurcated annual incentive tied to revenue and adjusted EBITDA with threshold/target/maximum payouts, PSUs for the CEO and CFO that vest only upon sustained stock‑price hurdles, and retention measures enacted during leadership transitions. The board frames the proposal as advisory and not binding, but notes that it values stockholder feedback and will investigate and respond to significant negative votes. Contextual factors include leadership transitions in 2025 (CEO change), a company-wide retention program, and the Compensation Committee’s recent review of pay practices with input from an independent consultant and peer benchmarking. Management highlights prior stockholder support (85% approval in 2025) and believes the current design balances retention needs, rigorous performance goals, and alignment with long‑term stockholder value creation. Potential concerns for analysts include the size and structure of CEO equity awards (large PSUs tied to stock-price hurdles), the use of retention payments and severance protections, and the risks that market conditions or accounting valuation methods may create disparities between realized and reported compensation. The Board’s recommendation ‘FOR’ is presented as a governance affirmation that the compensation program is working, while also signaling willingness to engage with stockholders if future votes indicate dissatisfaction.

This management proposal requests stockholder approval to amend the company’s Restated Certificate of Incorporation to permit a reverse stock split of common shares at a ratio in the 1‑for‑4 to 1‑for‑15 range, with the Board retaining discretion to select the exact ratio and to abandon or delay implementation if it determines doing so is in stockholders’ best interests. The Board’s principal stated purpose is to attempt to increase the per‑share market price to meet the NYSE’s minimum $1.00 closing price requirement after the company received a non‑compliance notice in December 2025; management asserts that approval and prompt implementation could restore compliance within the applicable cure period and avoid delisting. The proposal includes mechanics such as rounding down fractional shares (no cash-in‑lieu), proportional adjustments to outstanding equity awards and plan share reserves, and an increase in the pool of authorized but unissued shares available for future issuance. Key governance considerations include the Board’s retained discretion to (a) determine the precise ratio, (b) elect not to effect the reverse split even if approved, and (c) the effect on authorized shares which increases the Board’s flexibility to issue additional shares post-split. Potential benefits cited are improved perception among institutional investors, eligibility for broker and analyst coverage, and addressing NYSE listing standards; potential downsides include reduced liquidity from fewer shares outstanding, increased odd‑lot ownership and trading costs for small holders, no guarantee of a sustained price improvement, and effective increase in authorized unissued shares (which could enable greater dilution). NYSE rules also limit repeated use: if the stock again falls below $1.00 such that cumulative reverse-split ratios reach certain thresholds, the company could lose eligibility for further cure periods. The Board recommends FOR on balance, viewing the Reverse Stock Split as a necessary remedial step to preserve NYSE listing and improve marketability, while acknowledging the attendant risks and reserving the right to reassess before implementation.